News for Industry
International Stem Cell Corp Launches Stroke Program With Tulane (CNN)
(Carlsbad, CA) International Stem Cell Corporation launched a new stroke program in collaboration with Tulane University to examine neural stem cell transplantation in a preclinical rodent model.
Implanted Induced Neuron Stem Cells (iNSC) Become Part of the Brain (WWWEN)
(Luxemberg City, Luxemberg) Scientists have grafted neurons reprogrammed from skin cells into the brains of mice and have demonstrated long-term stability.
Cynata Therapeutics Inks Contract for Stem Cell Studies with WuXi AppTec (Proactive Investors)
(St. Paul, MN) Australia-based Cynata Therapeutics signed an agreement with Wuxi AppTech to conduct pre-clinical safety studies with a new stem cell technology.
Scientists Announce Technique to Create Red & White Blood Cells from PSCs (Medical XPress)
(Madison, WI) University of Wisconsin researchers have reported the discovery of 2 genetic programs responsible for turning pluripotent stem cells into red blood cells or an variety of white blood cells.
BioTime, Inc. Announces 14 New Patents For iPSC Applications (WSJ)
(Alameda, CA) BioTime announced the issuance of 14 new patents to add to the largest known patent estate under one corporate umbrella in the field of pluripotent stem cell technology.
Former CIRM Presidents Joins StemCells Inc.’s Board (SF Gate)
(Newark, NJ) StemCells Inc. announced the appointment of Dr. Alan Trounson who is the former president of the California Institute for Regenerative Medicine (CIRM).
Pevonia Launches New Stem Cell Skincare Line (Digital Journal)
(Daytona Beach, FL) A new skincare products using stem cells from two plant sources.
Pluripotent Stem Cells From Somatic Genetic Material Called Superior (RDMag)
(La Jolla, CA) Pluripotent stem cells created by injecting genetic material from a skin cell into an empty egg cell.
Scientists Withdraw Report on STAP Method of Simple iPSCs (AP)
(New York, NY) Scientists in the United States and Japan withdrawal report on the STAP method of inducing pluripotent stem cells (IPS).